论文部分内容阅读
[目的]观察丹红注射液联合生脉胶囊治疗冠心病心绞痛的临床效果。[方法]将收治的40例冠心病心绞痛患者随机分为实验组和对照组,对照组采用冠心病心绞痛常规治疗,实验组在对照组常规治疗基础上,使用丹红注射液联合生脉胶囊治疗。[结果]治疗组的总有效率为100%,对照组的总有效率为65.00%,差异具有统计学意义(P<0.05)。[结论]丹红注射液联合生脉胶囊治疗冠心病心绞痛的临床效果确切,联合用药安全、确切,不良反应少,好于单独给药,值得临床推广应用。
[Objective] To observe the clinical effect of Danhong Injection and Shengmai Capsule in treating angina pectoris of coronary heart disease. [Methods] 40 cases of patients with coronary heart disease angina pectoris were randomly divided into experimental group and control group, the control group were treated with conventional angina pectoris, the experimental group in the control group on the basis of conventional treatment, Danhong injection combined with Shengmai capsule . [Results] The total effective rate of the treatment group was 100%, while the total effective rate of the control group was 65.00%, the difference was statistically significant (P <0.05). [Conclusion] Danhong injection combined with Shengmai capsule in the treatment of coronary heart disease angina pectoris has the exact clinical effect. The combination therapy is safe, accurate and has few adverse reactions. It is better than the single administration and worthy of clinical application.